Matches in SemOpenAlex for { <https://semopenalex.org/work/W2910034530> ?p ?o ?g. }
- W2910034530 endingPage "129" @default.
- W2910034530 startingPage "113" @default.
- W2910034530 abstract "Coronary artery disease is the first cause of death across the world. Targeted delivery of therapeutics through controlled release of micro- and nano-particles remains a very capable approach to develop new strategies in treating restenosis and atherosclerotic plaques. In this research, to produce the arterial geometry, an image-processing was done using CT-scan images of a LAD coronary artery. After implementing the finite element mesh, the Fluid-Structure Interaction (FSI) simulation based on physiological boundary conditions was performed. Next, a Lagrangian description of particles dynamics in a non-Newtonian blood flow considering momentum equation of motion for each particle and the imposed external magnetic field was provided. Under the influence of the magnetic field, the optimal particle size scope for which the surface density of particles (SDP) adhered on the plaque lumen reaches its maximum was specified. Also, our results signify that applying a magnetic field can adversely affect the delivery of particles to the targeted site for near micron-size particles. Along with the evaluation of the Brownian and the gravitational forces on nanoparticles, the uniformity of the distribution of particles in the left coronary network with and without the presence of the magnetic field has been studied. In conclusion, the external magnetic field has increased the SDP adhered on the targeted surface by 49.4% and 59.7% for 400 and 600 nm particles, respectively." @default.
- W2910034530 created "2019-01-25" @default.
- W2910034530 creator A5046105290 @default.
- W2910034530 creator A5067484588 @default.
- W2910034530 creator A5071821401 @default.
- W2910034530 creator A5078760326 @default.
- W2910034530 date "2019-03-01" @default.
- W2910034530 modified "2023-10-16" @default.
- W2910034530 title "In silico study of patient-specific magnetic drug targeting for a coronary LAD atherosclerotic plaque" @default.
- W2910034530 cites W1125498713 @default.
- W2910034530 cites W1188715322 @default.
- W2910034530 cites W1278334305 @default.
- W2910034530 cites W1801840020 @default.
- W2910034530 cites W1964318214 @default.
- W2910034530 cites W1970369408 @default.
- W2910034530 cites W1971094951 @default.
- W2910034530 cites W1973326405 @default.
- W2910034530 cites W1975338551 @default.
- W2910034530 cites W1975965941 @default.
- W2910034530 cites W1980874266 @default.
- W2910034530 cites W1985750032 @default.
- W2910034530 cites W1987983909 @default.
- W2910034530 cites W1988217845 @default.
- W2910034530 cites W1989454578 @default.
- W2910034530 cites W1993706573 @default.
- W2910034530 cites W1995391213 @default.
- W2910034530 cites W1997435827 @default.
- W2910034530 cites W1997556854 @default.
- W2910034530 cites W2004048765 @default.
- W2910034530 cites W2006474652 @default.
- W2910034530 cites W2018478612 @default.
- W2910034530 cites W2023413997 @default.
- W2910034530 cites W2024697557 @default.
- W2910034530 cites W2027714927 @default.
- W2910034530 cites W2028281612 @default.
- W2910034530 cites W2030438521 @default.
- W2910034530 cites W2034049163 @default.
- W2910034530 cites W2034690046 @default.
- W2910034530 cites W2037585162 @default.
- W2910034530 cites W2051290526 @default.
- W2910034530 cites W2055596401 @default.
- W2910034530 cites W2065527895 @default.
- W2910034530 cites W2067824277 @default.
- W2910034530 cites W2071191024 @default.
- W2910034530 cites W2078239222 @default.
- W2910034530 cites W2080689908 @default.
- W2910034530 cites W2082043116 @default.
- W2910034530 cites W2082349971 @default.
- W2910034530 cites W2083373724 @default.
- W2910034530 cites W2086509552 @default.
- W2910034530 cites W2088170172 @default.
- W2910034530 cites W2094941678 @default.
- W2910034530 cites W2101782398 @default.
- W2910034530 cites W2102049252 @default.
- W2910034530 cites W2104041174 @default.
- W2910034530 cites W2119642538 @default.
- W2910034530 cites W2123849267 @default.
- W2910034530 cites W2129210116 @default.
- W2910034530 cites W2132005699 @default.
- W2910034530 cites W2133686388 @default.
- W2910034530 cites W2135629952 @default.
- W2910034530 cites W2147919356 @default.
- W2910034530 cites W2155809947 @default.
- W2910034530 cites W2169532237 @default.
- W2910034530 cites W2188899249 @default.
- W2910034530 cites W2292069171 @default.
- W2910034530 cites W2312378702 @default.
- W2910034530 cites W2322117467 @default.
- W2910034530 cites W2464260919 @default.
- W2910034530 cites W2485987065 @default.
- W2910034530 cites W2550600827 @default.
- W2910034530 cites W2608549666 @default.
- W2910034530 cites W2710292056 @default.
- W2910034530 cites W2746957719 @default.
- W2910034530 cites W2774304266 @default.
- W2910034530 cites W2795256563 @default.
- W2910034530 cites W2803094507 @default.
- W2910034530 cites W2889473055 @default.
- W2910034530 cites W3042164605 @default.
- W2910034530 cites W3104581299 @default.
- W2910034530 doi "https://doi.org/10.1016/j.ijpharm.2018.12.088" @default.
- W2910034530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30654060" @default.
- W2910034530 hasPublicationYear "2019" @default.
- W2910034530 type Work @default.
- W2910034530 sameAs 2910034530 @default.
- W2910034530 citedByCount "21" @default.
- W2910034530 countsByYear W29100345302020 @default.
- W2910034530 countsByYear W29100345302021 @default.
- W2910034530 countsByYear W29100345302022 @default.
- W2910034530 countsByYear W29100345302023 @default.
- W2910034530 crossrefType "journal-article" @default.
- W2910034530 hasAuthorship W2910034530A5046105290 @default.
- W2910034530 hasAuthorship W2910034530A5067484588 @default.
- W2910034530 hasAuthorship W2910034530A5071821401 @default.
- W2910034530 hasAuthorship W2910034530A5078760326 @default.
- W2910034530 hasConcept C112401455 @default.
- W2910034530 hasConcept C115260700 @default.
- W2910034530 hasConcept C121332964 @default.